Patent · US Active

Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes

US8178556B2 · kind B2 · utility

0Cited by

1References

15Claims

0Family size

Assignee

MERCK PATENT GESELLSCHAFT MIT BESHRANK TER HAFTUNG · DE

Inventors

Gerard Botton · Buc, FR
Eric Valeur · Brétigny-sur-Orge, FR
Micheline Kergoat · Les Ulis, FR
Christine Charon · Gometz-le-Châtel, FR
Samer Elbawab · Les Ulis, FR

Key dates

Filing date	Feb 27, 2009
Grant date	May 15, 2012
Priority date	—
Expiry date	Feb 27, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are pyridopyrazinone derivatives of formula (I),wherein X, Y, Z, W, A and R1 are as defined in claim 1, as insulin secretion stimulators. Also described is the preparation and use of these pyridopyrazinone derivatives for the prophylaxis and/or treatment of diabetes and pathologies associated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.